Oral or mouth cancer usually occur on the surfaces of tongue, lips,
cheek, gums, tonsils and salivary glands. An oral cancer is a type of
head and neck cancer; and it appears in the form of a tumor in the
mouth. Oral cancers can be benign or malignant. Benign tumors can be
removed with the help of surgery. 90% of malignant oral cancers comprise
of squamous cell carcinoma, which could spread to other parts of the
body. According to the Oral Cancer Foundation, every year around 53,000
new oral cancer cases are diagnosed and more than 9,750 people succumb
to the disease in the U.S. Oral cancer accounts for 4% of total cancer
cases and causes 2.2% of deaths in the U.S. In western countries,
prevalence of oral cancer is 2% to 6% of the total cancer cases. In Asia
Pacific, the oropharyngeal cancer is more common among men than women.
According to the National Cancer Institute, 60% of people with oral
cancer survive for five years or more and 70% to 90% of people with
Stage 1 or 2 cancer survive for more than 5 years.
Increase in incidence of oral cancers, surge in health care
expenditure, and rise in risk factors such as growing age, increase in
HPV16 are some factors driving the global oral cancer treatment market.
Additionally, increasing usage of tobacco worldwide is a major factor
driving the oral cancer treatment market. According to a report by the
World Health Organization (WHO), the worldwide tobacco use is 4 Million
which is growing annually and death caused due to tobacco is likely to
reach 10 million by 2020. Rising alcohol consumption across the globe is
also another major factor causing oral cancer. This, in turn, is likely
to propel the global oral cancer treatment market. Moreover, rise in
patient population and high investments by governments for providing
better oral cancer treatment are anticipated to propel the market during
the forecast period. However, ignoring early symptoms of oral cancer
and lack of awareness about the disease, especially in developing
countries is likely to restrain the global market.
Global oral cancer treatment market can be segmented based on type, treatment, end-users, and region. Based on type of oral cancer, the market can be classified into verrucous carcinoma, squamous cell carcinoma, minor salivary gland cancers, and others. Based on treatment, the global oral cancer treatment market can be categorized into surgery, radiation therapy, targeted therapy, chemotherapy, and others. In terms of end-users, the global market can be divided into hospitals, specialized cancer centers, and others.
In terms of region, the global oral cancer treatment market can be
segmented into North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa. Increase in demand for surgical therapies for
the treatment of oral cancer and rise in investment by governments in
research & development to improve treatments boost the global
market. North America dominated the global market in 2017 and this trend
is projected to continue during the forecast period owing to the rising
health care investments in the region and prevalence of oral cancer.
Europe is a major region for the oral cancer treatment market owing to
the availability of funds for oral cancer, huge patient population, and
high income of people in the region. The oral cancer treatment market in
Asia Pacific is anticipated to expand at a rapid pace during the
forecast period. Rise in tobacco usage, increase in smoking, rapidly
expanding health care industry, growing patient population, and high
unmet needs are likely to drive the oral cancer treatment market in the
region. Further, favorable government policies and rise in disposal
income are anticipated to propel the oral cancer treatment market in the
region during the forecast period.
Major players operating in the global oral cancer treatment market include Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
Global oral cancer treatment market can be segmented based on type, treatment, end-users, and region. Based on type of oral cancer, the market can be classified into verrucous carcinoma, squamous cell carcinoma, minor salivary gland cancers, and others. Based on treatment, the global oral cancer treatment market can be categorized into surgery, radiation therapy, targeted therapy, chemotherapy, and others. In terms of end-users, the global market can be divided into hospitals, specialized cancer centers, and others.
Major players operating in the global oral cancer treatment market include Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
No comments:
Post a Comment